share_log

Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome

Benzinga Real-time News ·  2021/12/06 08:11
Longeveron Shares Move Slightly Higher; Co. Issues PR Highlighting News From Friday The Company Was Granted Orphan Drug Designation By FDA For Lomecel-B To Treat Infants With Hypoplastic Left Heart Syndrome
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする